Pharma Wary Of Over-Flexible EU Plan For Electronic Product Information
Executive Summary
The pharmaceutical industry is concerned that too much flexibility may result in a “fragmented and cost intensive implementation” of the EU electronic product information framework.
You may also be interested in...
EU Commits To Flexibility On EPI
EU regulators have adopted key principles for using electronic product information for human medicines, which are now expected to be followed by all parties involved in developing and implementing ePI.
EU Commits To Flexibility On Electronic Product Information
EU regulators have adopted key principles for using electronic product information for human medicines, which are now expected to be followed by all parties involved in developing and implementing ePI.
EU Steps Up Electronic Product Information Plans; Promises Flexibility
Comments are being invited on draft key principles that will form the basis on which ePI for medicines will be developed and used in the EU.